Diminished effect of transdermal fentanyl in the terminal phase?
Davies
A
A
Prentice
W
W
D000279:Administration, Cutaneous; D000701:Analgesics, Opioid / Q000493:pharmacokinetics*; D004361:Drug Tolerance; D005283:Fentanyl / Q000493:pharmacokinetics*; D006801:Humans; D013727:Terminal Care
D000701:Analgesics, Opioid; D005283:Fentanyl